We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
In a clinical study, which has already received ethics approval and will start very soon, sera from convalescent COVID-19 patients will be tested for virus neutralization capacity and for epitope mapping.